Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
-
Published:2020-06-12
Issue:8
Volume:47
Page:572-579
-
ISSN:0306-6800
-
Container-title:Journal of Medical Ethics
-
language:en
-
Short-container-title:J Med Ethics
Abstract
Research Ethics Committees (RECs) play a critical gatekeeping role in clinical trials. This role is meant to ensure that only those trials that meet certain ethical thresholds proceed through their gate. Two of these thresholds are that the potential benefits of trials are reasonable in relation to risks and that trials are capable of producing a requisite amount of social value. While one ought not expect perfect execution by RECs of their gatekeeping role, one should expect routine success in it. This article reviews a range of evidence showing that substantial numbers of ethically tainted trials are receiving REC approvals. Many of the trials are early phase trials that evidence shows have benefits that may not be reasonable compared with their risks and many others are later trials that evidence shows may lack sufficient social value. The evidence pertains to such matters as methodologically inadequate preclinical studies incapable of supporting the inferences that REC members must make about the prospects for potential benefit needed to offset the risks in early phase trials and sponsorship bias that can cause improperly designed, conducted, analysed and reported later phase trials. The analysis of the evidence makes clear that REC practices need to be strengthened if they are to adequately fulfil their gatekeeping role. The article also explores options that RECs could use in order to improve their gatekeeping function.
Funder
National Center for Advancing Translational Sciences, National Institutes of Health
Subject
Health Policy,Arts and Humanities (miscellaneous),Issues, ethics and legal aspects,Health (social science)
Reference68 articles.
1. American association for the advancement of science. Available: http://www.aaas.org/aboutaaas/
2. National Institutes of Health . Mission and goals. Available: https://www.nih.gov/about-nih/what-we-do/mission-goals
3. Fauci A , 2020. Available: https://www.youtube.com/watch?v=dqE3bKRgY6o [Accessed May 20,2020].
4. Prescrire international. 2019 Prescrire drug awards 2020.
5. Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献